arrow
Back
S

Stefan N. Symeonides

guy's & st thomas' nhs foundation trust

25H-index
214Paper Count
3.7KCitation Count
Published Papers 46
Publication Date
Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trial
err2026-05-01
err0
PREAI
errMelero, Ignacio; Reis, Bernhard; Rusterholz, Corinne; Epp, Alexandra; Kratochwil, Nicole A.; Wu, Chun; Hettich, Michael; Kazantzidis, Georgios; Rieder, Natascha; Schwalie, Petra C.; Badillo, Solveig; Kumpesa, Nadine; Thommen, Andreas; Vugts, Danielle J.; Moreno, Victor; Lostes Bardaji, Julia; Alvarez, Eduardo Castanon; de Andrea, Carlos E.; Spanggaard, Iben; Lee, Dae Ho; Spicer, James; Thistlethwaite, Fiona; Oh, Do-Youn; Hollebecque, Antoine; Cirovic, Olivera; Symeonides, Stefan N.
errShare
errSave
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)
err2026-03-17
err0
PREAI
errEmily Alger; Antoine Regnault; Amylou C Dueck; Madeline Pe; Michael J Grayling; Melanie J Calvert; Aaron R Hansen; Olga Kholmanskikh; Julia Lai-Kwon; J Jack Lee; Anna Minchom; Yu Qiao; Khadija Rerhou Rantell; Jessica Roydhouse; Claire Snyder; Stefan N Symeonides; Nolan A Wages; Roger Wilson; Christina Yap
errShare
errSave
Innovative oncology trial designs: Time to act - A review with recommendations of the Cancer Drug Development Forum
err2026-02-01
err0
PREAI
errGiuliani, Rosa; Kronidou-Horst, Nafsika; Yap, Christina; Mejia, Aaron Sosa; Leyens, Lada; Framke, Theodor; Sweeney, Fergus; Collette, Laurence; Giles, Rachel; Bogaerts, Jan; Van De Ven, Peter; Symeonides, Stefan N.
errShare
errSave
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology
err2025-11-08
err0
errOAAI
errRichard Phillips; Bristi Basu; Zohra Butt; Mounia Beloueche; Natalie Cook; Simon J. Crabb; Alastair Greystoke; Darren Hargrave; Robert Jones; Muhammad Yasin Kureeman; Juanita Lopez; Claire McKeeve; Magdalena Meissner; Brent O’Carrigan; Eileen E. Parkes; Milind Ronghe; Patricia Roxburgh; Debashis Sarker; Kienan I. Savage; Paul H. S. Shaw; Stefan Symeonides; Deborah A. Tweddle; Aditi Vedi; Harriet S. Walter; Joanna Zabkiewicz; Gary W. Middleton; Andrew D. Beggs
errShare
errSave
Leveraging knowledge for explainable AI in personalized cancer treatment: challenges and future directions
err2025-09-29
err0
errOAAI
errEmilia Daghir-Wojtkowiak†; Javier Alfaro†; Michele Mastromattei; Aleksander Palkowski; Mark Stares; Ana Roca-Umbert; Andraz Krajnc; Riccardo Leoni; Anne Boland; Aria Nourbaksh; Ashwin Kallor; Camille Ducki; Davide Venditti; Carla Montesano; Chiara Cipriani; Daniel Faria; Delphine Pflieger; Elisa Zago; Etienne Bardet; Filipa Serrano; Florian Jeanneret; Damien Alouges; Liangwei Yin; Elodine Coquelet; Apolline Bacquet; Francesco Bonchi; Francesco Maiorino; Francesco Torino; Georges Bedran; Jean-Alexandre Long; Laura Balbi; Laurent Guyon; Liana Bevilacqua; Manuel Fiorelli; Marie-Catherine Wagner; Mario Reyes; Mario Roselli; Marta Contreiras Silva; Michal Waleron; Nikolas Dovrolis; Odile Filhol-Cochet; In Hwa Um; Georg Wolflein; Patrícia Eugénio; Pauline Bazelle; Pavlos Golnas; Peter Thorpe; Pierluigi Bove; Piyush Borole; Roberta Bernardini; Rohit Kumar; Rosella Cicconi; Saskia Kaltenbrunner; Saverio Gravina; Simona Brezar; Stefan Symeonides; Steven McGinn; Susana Nunes; Ted Hupp; Yuri Gordienko; Dimitrios Varvaras; Sergii Stirenko; Luciano Xumerle; Stefania Mariani; Assilah Bouzit; Stéphane Gazut; Heiko Poth; Kyriakos Souliotis; Hector Katifelis; Elena Verzoni; Giuseppe Procopio; Sarah Schoch; Francisco Lupiáñez-Villanueva; Sandra Türk; Katarzyna Barud; Dimitri Koroliouk‡; Juan Caubet‡; Yamir Moreno‡; Jean-Luc Descotes‡; Christina Golna‡; Valentina Guadalupi‡; Paolo Garagnani‡; Maria Gazouli‡; Jean-François Deleuze‡; Frans Folkvord‡; Nikolaus Forgó‡; David J. Harrison‡; Håkan Axelson‡; Armando Stellato‡; Maurizio Mattei‡; Ajitha Rajan‡; Alexander Laird‡; Christophe Battail‡; Catia Pesquita‡; Fabio Massimo Zanzotto§
errShare
errSave
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial
err2025-06-27
err0
errOAAI
errSusana Banerjee; Matthew G. Krebs; Alastair Greystoke; Alvaro Ingles Garces; Vicky Sanchez Perez; Angelika Terbuch; Rajiv Shinde; Reece Caldwell; Rafael Grochot; Mahtab Rouhifard; Ruth Ruddle; Bora Gurel; Karen Swales; Nina Tunariu; Toby Prout; Mona Parmar; Stefan Symeonides; Jan Rekowski; Christina Yap; Adam Sharp; Alec Paschalis; Juanita Lopez; Anna Minchom; Johann Sebastian de Bono; Udai Banerji
errShare
errSave
Impact of systemic anticancer therapy timing on cancer vaccine immunogenicity: a review
err2025-02-27
err0
errOAAI
errIgor Gomez-Randulfe; Helen Lavender; Stefan Symeonides; Fiona Blackhall
errShare
errSave
The integrin adhesome and control of anti-tumour immunity
err2024-12-06
err2
PREAI
errWebb, Emily R.; Black, Annabel; Barth, Nicole D.; Symeonides, Stefan N.; Brunton, Valerie G.
errShare
errSave
Fibroblast activation protein (FAP)-CD40 (RO7300490) mediates intratumoral DC maturation and modulation of the tumor microenvironment
err2024-09-01
err0
PREAI
errMelero, I.; Reis, B.; Lostes Bardaji, M. J.; Spanggaard, I.; Lee, D. H.; Spicer, J.; Thistlethwaite, F.; Symeonides, S. N.; Oh, D-Y.; Hollebecque, A.; Rieder, N.; Schwalie, P.; Badillo, S.; Kumpesa, N.; Thommen, A.; Rusterholz, C.; Cirovic, O.; Kazantzidis, G.; Garcia, V. Moreno; Epp, A.
errShare
errSave
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
err2024-04-18
err40
PREAI
errChoueiri, T. K.; Tomczak, P.; Park, S. H.; Venugopal, B.; Ferguson, T.; Symeonides, S. N.; Hajek, J.; Chang, Y-H; Lee, J-L; Sarwar, N.; Haas, N. B.; Gurney, H.; Sawrycki, P.; Mahave, M.; Gross-Goupil, M.; Zhang, T.; Burke, J. M.; Doshi, G.; Melichar, B.; Kopyltsov, E.; Alva, A.; Oudard, S.; Topart, D.; Hammers, H.; Kitamura, H.; McDermott, D. F.; Silva, A.; Winquist, E.; Cornell, J.; Elfiky, A.; Burgents, J. E.; Perini, R. F.; Powles, T.
errShare
errSave
RNA regulatory disruption by 3′-dATP: A novel approach to inhibit ribosome biogenesis in cancer
err2024-03-22
err0
PREAI
errElshani, Mustafa; Zhang, Ying; Um, In Hwa; Plummer, Ruth; Blagden, Sarah P.; Symeonides, Stefan N.; Cook, Natalie; Evans, T. R. Jeffry; Dickson, Alison L.; Harrison, David J.
errShare
errSave
Exposing the heterogeneity of the lipidome in the TME of cutaneous melanoma following treatment with NUC-7738 in combination with anti-PD-1 therapy
err2024-03-22
err0
PREAI
errDickson, Alison L.; Zickuhr, Greice M.; Um, In Hwa; Zhang, Ying; Plummer, Ruth; Blagden, Sarah P.; Symeonides, Stefan N.; Cook, Natalie; Evans, T. R. Jeffry; Elshani, Mustafa; Harrison, David J.
errShare
errSave
NUC-7738 in combination with pembrolizumab in patients with metastatic melanoma: Phase 2 results from the NuTide:701 study
err2023-12-01
err0
PREAI
errBlagden, Sarah P.; Symeonides, Stefan N.; Skolariki, Aglaia; Hans, Noor Md; Boh, Zhuang; Um, In Hwa; Elshani, Mustafa; Dickson, Alison L.; Zhang, Ying; Harrison, David J.; McKissock, Fiona G.; Oelmann, Elisabeth; Bloss, Jeffrey D.; Cook, Natalie; Evans, T. R. Jeffry; Plummer, E. Ruth
errShare
errSave
A phase I/IIa trial of ChAdOx1 and MVA vaccines against MAGE-A3 and NY-ESO-1
err2023-10-01
err1
PREAI
errBlackhall, F.; Moliner, L.; Samson, A.; Franks, K.; Karydis, I.; Joseph-Pietras, D.; Frank, O.; Lavender, H.; Jannoo, M.; Marshall, M.; Motteram, P.; Van den Eynde, B. J.; Leung, C.; Hill, A.; Middleton, M. R.; Coupe, N. A.; Steele, N.; Spicer, J.; Shaw, P. H.; Symeonides, S. N.
errShare
errSave
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer
err2023-04-29
err18
errOAAI
errKristeleit, Rebecca; Plummer, Ruth; Jones, Robert; Carter, Louise; Blagden, Sarah; Sarker, Debashis; Arkenau, Tobias; Evans, Thomas R. Jeffry; Danson, Sarah; Symeonides, Stefan N.; Veal, Gareth J.; Klencke, Barbara J.; Kowalski, Mark M.; Banerji, Udai
errShare
errSave
NUC-7738 causes reduction of soluble and exosome-associated PD-L1 in melanoma cell lines and patients
err2023-04-04
err0
PREAI
errElshani, Mustafa; Zhang, Ying; Kaghazchi, Boback; Dickson, Alison L.; Blagden, Sarah P.; Symeonides, Stefan; Plummer, Ruth; Harrison, David J.
errShare
errSave
Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study
err2023-03-02
err7
errOAAI
errOswald, Ailsa J.; Symeonides, Stefan N.; Wheatley, Duncan; Chan, Stephen; Brunt, Adrian Murray; McAdam, Karen; Schmid, Peter; Waters, Simon; Poole, Christopher; Twelves, Chris; Perren, Timothy; Bartlett, John; Piper, Tammy; Chisholm, Eve Macdonald; Welsh, Michelle; Hill, Robert; Hopcroft, Lisa E. M.; Barrett-Lee, Peter; Cameron, David A.
errShare
errSave
Single-cell RNA sequencing of human breast tumour-infiltrating immune cells reveals a γδ T-cell subtype associated with good clinical outcome (vol 4, e202000680, 2022)
err2022-12-13
err0
errOAAI
errBoufea, Katerina; Gonzalez-Huici, Victor; Lindberg, Marcus; Olova, Nelly N.; Symeonides, Stefan; Oikonomidou, Olga; Batada, Nizar N.
errShare
errSave
ST101, A PEPTIDE ANTAGONIST OF NOVEL I/O TARGET CEBPβ, REPROGRAMS MDSC POLARIZATION AND DECREASES TUMOR-ASSOCIATED TREGS, SUGGESTING AN IMMUNE COMPONENT TO OBSERVED CLINICAL RESPONSES
err2022-11-07
err0
errOAAI
errScuoppo, Claudio; Falchook, Gerald; Fontana, Elisa; Williams, Anja; Lakhani, Nehal; Evans, Jeff; Iwamoto, Fabio; McKean, Meredith; Symeonides, Stefan; McLaren, Alistair; Henry, Jason; Capiaux, Gina; Michel, Robert; Kaesshaefer, Stephen; Bexon, Alice; Rotolo, Jim
errShare
errSave